MedTrace Logo

The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage

NCT03209063 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 285

Last updated 2022-06-30

No results posted yet for this study

Summary

Recurrent miscarriage is a pregnancy loss before 20 weeks of gestation. The recurrent pregnancy loss(RPL) usually occurring in the first trimester of gestation and its rate is quite high (15-20% even in full reproductive period) . In 2012, the American Society for Reproductive Medicine Practice Committee issued a statement that defined recurrent pregnancy loss as a disease distinct from infertility defined by two or more failed consecutive pregnancies.approximately 40% of couples will have an etiology identified that could be associated with their loss.

Conditions

  • Recurrent Miscarriage

Interventions

DIAGNOSTIC_TEST

polymerase chain reaction

diagnostic test as Polymerase chain reaction for detection of Prothrombin gene and methylenetetrahydrofolate reductase gene polymorphisms

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ghada M Mahran, MD · Assiut University, Faculty of medicine

Eligibility

Min Age
17 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-08-01
Completion
2022-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209063 on ClinicalTrials.gov